WINDTREE THERAPEUTICS INC (WINT)

Company Profile

Windtree Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Warrington, Pennsylvania and currently employs 15 full-time employees. Windtree Therapeutics, Inc. is a biotechnology company. The firm is focused on advancing early and late-stage therapies for critical conditions and diseases. The Company’s portfolio of product candidates includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, and preclinical precision aPKCi inhibitors that are being developed for potential in rare and broad oncology applications. Its lead product candidate, istaroxime, is a dual-acting agent being developed to increase blood pressure and improve cardiac function in patients with cardiogenic shock and to improve cardiac function in patients with acute heart failure (AHF) and reverse the hypotension and hypoperfusion associated with heart failure that deteriorates to cardiogenic shock. The firm also has a licensing business model with partnership out-licenses in place.

Company Info

WINDTREE THERAPEUTICS INC

2600 Kelly Rd Ste 100

Warrington PENNSYLVANIA 18976

P: 12154889300

CEO: Craig E. Fraser

Employees: 20

Website: https://windtreetx.com/